Role of platinum agents in the management of advanced pancreatic cancer

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.8, Iss.16, 2007-11, pp. : 2719-2727

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Androgen Receptor-Blocking Agents: Potential Role in Pancreatic Cancer

By Greenway B.A.

Drugs & Aging, Vol. 17, Iss. 3, 2000-09 ,pp. : 161-163

Adis International

Access to resources Recommend Favorite

Incorporation of Targeted Agents in the Management of Patients with Advanced Gastric Cancer

Current Medicinal Chemistry, Vol. 18, Iss. 11, 2011-04 ,pp. : 1629-1639

Bentham Science Publishers

Access to resources Recommend Favorite

Role of the RAS in Pancreatic Cancer

Current Cancer Drug Targets, Vol. 11, Iss. 4, 2011-05 ,pp. : 412-420

Bentham Science Publishers

Access to resources Recommend Favorite

Investigational agents against platinum-resistant ovarian cancer

By Lorusso Domenica Ferrandina Gabriella Fanfani Francesco Gagliardi Maria Lucia Scambia Giovanni

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 3, 2007-03 ,pp. : 325-336

Informa Healthcare

Access to resources Recommend Favorite

Trastuzumab/docetaxel/platinum salts for advanced breast cancer

Inpharma, Vol. 1, Iss. 1442, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite